Boston Medical Center and Boston University researchers one step closer to developing cell-based therapy for hypothyroidism
Researchers from Boston Medical Center and Boston University have made a breakthrough that holds promise for developing new therapies to treat hypothyroidism, a condition where the thyroid gland does ...
Future Market Insights1d
Global Allogeneic T-cell Therapies Market Poised for Significant Growth, Projected to Reach USD 3.08 Billion by 2033
According to a recent report from Future Market Insights, the global allogeneic T-cell therapies market was valued at USD 1.1 ...
Targeted Oncology13d
Balancing Risk and Efficacy in Follicular Lymphoma Treatment
Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.
pharmaphorum2d
Kymriah is first CAR-T cleared for follicular lymphoma in EU
Follicular lymphoma is the ... earlier approvals for diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukaemia. Kymriah was the first CAR-T to reach the market in 2017, but was ...
The EMBO Journal10d
Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
The hair follicle is a dynamic miniature organ. Its permanent portion opens to the skin surface, communicates with sebaceous ...
Pharmabiz13d
Kite to present CAR T-cell therapy portfolio across a spectrum of blood cancers during the 66th ASH meeting
Santa Monica, California Thursday, November 7, 2024, 10:00 Hrs [IST] ...